Get the Stockscreener App
0.9487
8.78%
-0.0914
After Hours:
.96
0.0114
+1.20%
AEON Biopharma Inc. stock is traded at $0.9487, with a volume of 166.58K.
It is down -8.78% in the last 24 hours and down -13.80% over the past month.
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.
See More
Previous Close:
$1.04
Open:
$1.0371
24h Volume:
166.58K
Relative Volume:
0.75
Market Cap:
$24.00M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-11.34%
1M Performance:
-13.80%
6M Performance:
+37.65%
1Y Performance:
-90.31%
1-Day Range:
$0.9112
$1.0371
1-Week Range:
$0.9112
$1.13
52-Week Range:
$0.375
$9.7128
AEON Biopharma Inc. Stock (AEON) Company Profile
Name
AEON Biopharma Inc.
Sector
Industry
Phone
(949) 354-6499
Address
5 Park Plaza, Suite 1750, Irvine
Compare AEON vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
0.9487 | 26.32M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-23 | Initiated | H.C. Wainwright | Buy |
AEON Biopharma Inc. Stock (AEON) Latest News
Short Covering: Can AEON Biopharma Inc. weather a recessionWeekly Trading Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn
Profit Review: Is AEON Biopharma Inc in a long term uptrendMarket Sentiment Summary & Daily Stock Trend Reports - baoquankhu1.vn
Midday Stock Roundup: MDxHealth Up 9% Since Preliminary Q4, FY Results - Orange County Business Journal
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions - The Manila Times
AEON Biopharma completes FDA meeting, shareholders approve transactions - Investing.com
Aeon Biopharma stock falls after FDA meeting and debt restructuring By Investing.com - Investing.com Nigeria
Aeon Biopharma stock falls after FDA meeting and debt restructuring - Investing.com
Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions - TradingView
AEON Biopharma completes FDA meeting, shareholders approve transactions By Investing.com - Investing.com Nigeria
Shareholders back AEON debt-cut deals after FDA meeting on Botox biosimilar - Stock Titan
Growth Value: Is AEON Biopharma Inc stock good for income investorsQuarterly Trade Summary & Community Supported Trade Ideas - baoquankhu1.vn
Is EverQuote Inc. stock attractive for passive investorsWeekly Investment Summary & Long-Term Safe Return Strategies - bollywoodhelpline.com
Midday Stock Roundup: loanDepot Jumps on Trump’s Proposed Mortgage Plan - Orange County Business Journal
Rate Cut: Whats the MACD signal for AEON Biopharma Inc2025 Macro Impact & AI Powered Market Entry Ideas - baoquankhu1.vn
Do Not Use - ocbj.com
Market Wrap: Can AEON Biopharma Inc keep up with sector leadersJuly 2025 Rallies & Risk Controlled Swing Alerts - baoquankhu1.vn
AEON Biopharma (AEON) Price Target Decreased by 14.75% to 5.30 - Nasdaq
Midday Stock Roundup: Staar Down 4% on Board Changes - Orange County Business Journal
AEON Biopharma Releases Updated Investor Presentation Under Reg FD - TipRanks
AEON Biopharma, Inc. Unveils Biosimilar Strategy for ABP-450 - TradingView
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - MSN
Midday Stock Roundup: loanDepot Rises on Trump Move - Orange County Business Journal
AEON Biopharma (NASDAQ:AEON) & Synaptogenix (NASDAQ:TAOX) Head to Head Analysis - Defense World
Why AEON Biopharma Inc. Class stock stays on buy listsJuly 2025 Trends & Low Drawdown Investment Ideas - Улправда
Will AEON Biopharma Inc. Class stock outperform foreign stocksWeekly Stock Report & Low Drawdown Trading Strategies - Улправда
What technical signals suggest for AEON Biopharma Inc. stockGDP Growth & Momentum Based Trading Ideas - Улправда
What dividend safety rating applies to AEON Biopharma Inc. Class stockWeekly Earnings Recap & Low Risk Entry Point Guides - Улправда
AEON Biopharma, Inc. Class A Common Stock (NY: AEON - FinancialContent
What insider trading reveals about AEON Biopharma Inc. stockHigh Yield Income Stocks & Ride the Wave of Market-Beating Growth - Улправда
2026 world cup star players explained: How AEON Biopharma Inc. Class stock compares with tech leaders2026 world cup usa national team third place match key players pressing system expert forecast preview - ulpravda.ru
2026 world cup match report guide: How AEON Biopharma Inc. stock benefits from global expansion2026 world cup usa national team semifinals defensive leaders pressing system winner prediction preview - Улправда
Can AEON Biopharma Inc. Class stock stage a strong rebound this quarter2026 world cup usa national team qualification playmakers high defensive line odds analysis preview - Улправда
Midday Stock Roundup: Rivian Down on Production Totals - Orange County Business Journal
AEON Biopharma, Inc. (AEON) Stock Forecast & Price Prediction 2025–2030 - CoinCodex
AEON Biopharma (NASDAQ:AEON) Trading Up 5.9% – Time to Buy? - Defense World
AEON Biopharma (AEON) seeks shareholder approval for PIPE, note exchange and equity plan - Stock Titan
Will AEON Biopharma Inc. stock split attract more investorsMarket Sentiment Indicators & Calculate Profit Targets With AI Accuracy - bollywoodhelpline.com
Midday Stock Roundup: Shimmick Corp. climbs 14% - Orange County Business Journal
Aug EndMonth: How AEON Biopharma Inc stock benefits from global expansionWeekly Profit Recap & Risk Managed Investment Strategies - moha.gov.vn
Insider Buy: Can AEON Biopharma Inc Class stock stage a strong rebound this quarterJuly 2025 Rallies & Low Drawdown Trading Techniques - moha.gov.vn
Is AEON Biopharma Inc. Class stock bottoming after sell offBond Market & Community Verified Trade Signals - Улправда
Investor Mood: Can AEON Biopharma Inc. Class stock stage a strong rebound this quarter - Улправда
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - The Manila Times
How AEON Biopharma Inc. stock benefits from global expansionEarnings Recap Summary & Weekly High Potential Stock Alerts - Улправда
AEONAeon Biopharma Latest Stock News & Market Updates - Stock Titan
Will AEON Biopharma Inc. Class stock benefit from infrastructure billWeekly Trading Summary & Reliable Breakout Stock Forecasts - Улправда
Biopharmaceutical company offers new hires stock units over four years - Stock Titan
AEON Biopharma Inc. Stock (AEON) Financials Data
There is no financial data for AEON Biopharma Inc. (AEON). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Cap:
|
Volume (24h):